ABIONIC
Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergy profiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection. Abionic ... SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements. Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab. Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland. Abionic appreciates the support it has received from:
ABIONIC
Industry:
Biotechnology Health Care Life Science Medical Nanotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.abionic.com
Total Employee:
51+
Status:
Active
Contact:
(412) 169-3825
Email Addresses:
[email protected]
Total Funding:
26.53 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Apache Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Investors List
Pierangelo Bottinelli
Pierangelo Bottinelli investment in Series C - Abionic
Jean- Bernard
Jean- Bernard investment in Series C - Abionic
Arkady Volozh
Arkady Volozh investment in Series C - Abionic
Peter Letmathe
Peter Letmathe investment in Series C - Abionic
Philippe Glatz
Philippe Glatz investment in Series C - Abionic
Verve Ventures
Verve Ventures investment in Series C - Abionic
Nelson Dumas
Nelson Dumas investment in Series C - Abionic
3wVentures
3wVentures investment in Series C - Abionic
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series C - Abionic
MedHoldings
MedHoldings investment in Series B - Abionic
Official Site Inspections
http://www.abionic.com Semrush global rank: 9.81 M Semrush visits lastest month: 102
- Host name: h2web75.infomaniak.ch
- IP address: 83.166.138.21
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Abionic"
Home | Abionic
The winner of multiple industry awards, including "Swiss MedTech of the year" in 2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform …See details»
Abionic - Crunchbase Company Profile & Funding
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. Abionic may be growing as it has formed a strategic collaboration for PSP Sepsis Diagnosis in China, which indicates an …See details»
Abionic - Wikipedia
Abionic SA is a company specialized in the development of ultra-rapid in vitro diagnostic tests, located in Lausanne, Switzerland. Abionic has developed the abioSCOPE, a point-of-care diagnostic platform using its patented nanofluidic technology. The abioSCOPE is implemented in intensive care units and emergency departments to enable early identification …See details»
Abionic - Contacts, Employees, Board Members, Advisors & Alumni
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.See details»
Abionic SA - Swiss Biotech
Abionic has developed a revolutionary nanofluidic technology providing professionals a unique and ultra-fast point of care diagnostic tool allowing immediate access to results for a large …See details»
Abionic - LinkedIn
The winner of multiple industry awards, including "Swiss MedTech of the year" in 2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform diagnostics.See details»
Abionic Company Profile 2024: Valuation, Funding
Abionic General Information Description. Developer of a nanotechnology-based revolutionary biomedical diagnostic platform designed to improve medical diagnosis. The company's nanofluidic technology-based diagnostic platform …See details»
Abionic - Funding, Financials, Valuation & Investors - Crunchbase
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Abionic Company Profile - Office Locations, Competitors ... - Craft
Abionic has 5 employees at their 1 location and $27.44 m in total funding,. See insights on Abionic including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Nicolas Durand interview | EY – Switzerland
Nicolas Durand is the founder and CEO of Abionic SA, the company that developed the fastest in vitrodiagnostic platform in the world, the abioSCOPE. ... EY refers to the global organization, and may refer to one or more, of the …See details»
Abionic - Overview, News & Similar companies | ZoomInfo.com
Nov 30, 2021 Who is Abionic. Founded in 2010, Abionic is a Swiss Medtech company commercializing a revolutionary nanofluidic technology, providing healthcare professionals …See details»
Abionic Signs Agreement to Optimize Asthma Management in the …
Sep 5, 2019 Abionic SA Dr. Nicolas Durand, CEO +41 (0)21 353 33 80 [email protected] Abionic SA Address Biopole SE-B, Corniche 5 CH-1066 Epalinges, Switzerland …See details»
Sepsis Alliance Institute: Abionic: Sepsis Advocate
2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform diagnostics. Our flagship abioSCOPE®, a near-patient rapid diagnostic …See details»
BioAlps | 20 years of innovation | Abionic
Nov 1, 2024 The following article is presented to you by Abionic. Presentation of Abionic’s activities. Swiss-based scale-up Abionic has developed a nanotechnology, which makes it …See details»
Abionic - Vaud Success Stories
Abionic was established in Lausanne and has benefited from various types of support from local economic development bodies, most notably SPEI. "This dynamic and incredibly well-run state …See details»
Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid ...
Aug 9, 2022 About Abionic Founded in 2010, Abionic is a Swiss Medtech company commercializing a revolutionary nanofluidic technology, providing healthcare professionals …See details»
Abionic Integrates First Patients in US Clinical Trial for Sepsis ...
Jan 9, 2020 BIOPÔLE LAUSANNE, Switzerland--(BUSINESS WIRE)--Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US for an innovative …See details»
Abionic: International Pivotal Study Successfully Demonstrates ...
• The World Health Organization (WHO) made sepsis a global health priority.4 • Mortality increases 8% every hour that the treatment is delayed. If diagnosed with Sepsis and treated in …See details»
Abionic Launches First Covid-19 Severity Test to Triage Patients ...
Nov 26, 2020 Abionic SA Dr. Nicolas Durand, CEO +41 (0)21 353 33 80 [email protected] Farner Consulting Chris Cartwright +41 78 800 62 90 [email protected] Site NavigationSee details»
The AI Advantage of Bionic Companies | Infographic | BCG
BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm …See details»